19-2276414-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198532.3(PEAK3):c.688C>A(p.Leu230Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000901 in 1,597,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198532.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEAK3 | NM_198532.3 | c.688C>A | p.Leu230Met | missense_variant | 4/4 | ENST00000342063.5 | NP_940934.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEAK3 | ENST00000342063.5 | c.688C>A | p.Leu230Met | missense_variant | 4/4 | 2 | NM_198532.3 | ENSP00000345102.3 | ||
ENSG00000273734 | ENST00000621615.1 | n.146+6670G>T | intron_variant | 2 | ENSP00000481965.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000489 AC: 11AN: 224856Hom.: 0 AF XY: 0.0000320 AC XY: 4AN XY: 124870
GnomAD4 exome AF: 0.0000872 AC: 126AN: 1445362Hom.: 0 Cov.: 31 AF XY: 0.0000821 AC XY: 59AN XY: 718830
GnomAD4 genome AF: 0.000118 AC: 18AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.688C>A (p.L230M) alteration is located in exon 4 (coding exon 3) of the C19orf35 gene. This alteration results from a C to A substitution at nucleotide position 688, causing the leucine (L) at amino acid position 230 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at